China
Wu Xiaohui of Wanhuida Intellectual Property explains why a recent decision on inventiveness assessments of co-solvent compound crystals heralds a significant shift in focus by the CNIPA, with implications for pharmaceutical patent strategies
Loeb & Loeb has taken on the IP, corporate and compliance teams from Perkins Coie’s soon-to-be closed Beijing office
In-house counsel believe Chinese domestic firms are becoming as sophisticated as international firms, but they may not shift their portfolios just yet
Tom Treutler, who previously managed the Vietnamese office of Tilleke & Gibbins, has joined East IP
Sponsored
Sponsored
-
Sponsored by Tahota Law FirmIn the first article of a two-part series, Charles Feng, Lian Xue, and Runjing Wang of Tahota Law Firm consider the different perspectives on whether China’s Anti-Unfair Competition Law should regulate internet advertising blocking -
Sponsored by Tahota Law FirmA two-part series concludes with Charles Feng, Lian Xue, and Runjing Wang of Tahota Law Firm analysing relevant Chinese case law in assessing whether the mobile application LiTiaotiao constitutes unfair competition
-
Sponsored by Liu Shen & AssociatesXuelan Yue of Liu Shen & Associates draws on several ‘model cases’ put forward by the Intellectual Property Court of the Supreme People’s Court of China to highlight trends in trade secret infringement cases
-
Sponsored by Wanhuida Intellectual PropertyA ruling on the inventiveness of a compound patent for a prostate cancer therapeutic could help create uniform jurisprudence regarding the examination of pharmaceutical patents, says Guan Yue of Wanhuida Intellectual Property
-
Sponsored by Bird & BirdMeyke Rietveld and Clemens Molle of Bird & Bird, along with Emma Ren from the association team at Beijing Lawjay Partners, discuss the first copyright cases in China and the EU dealing with training AI models, and newly enacted legislation in this field
-
Sponsored by Wanhuida Intellectual PropertyRui Wang of Wanhuida Intellectual Property says inventors should focus on improving AI systems’ transparency and predictability to enhance their patentability and identifies a challenge resulting from the interdisciplinary techniques involved in examination
